Blog / Archives
Trading the Biotech Bottom in 2018 in an Ambivalent Market…Updates ASH TSRO XBI
Update-2 December 3 ...Our Top Pick TSRO is up 58% on GSK Buyout We recommended Tesaro (TSRO) at $34 and it paid off today with a ~$5.1B buyout by GlaxoSmith Kline! Year End Rally Intact with XBI up...
Trade the Seasonal Rally in Biotech Off the 2018 Bottom…Updates AMGN TSRO XBI
Update for the Week: Trying to Find the Bottom-Choppy Action But Tradeable XBI holds above $74.62 bottom up 1.3% for the week but can't hold today's gains. AMGN flat for the week at $193 but can't...
2018 Biopharmaceutical Performance-Large Caps: Big winners were Merck and Vertex…Update- Rally Underway
11/16...TSRO Alert at $35, Up 32%, Company is for Sale 11/15p After Close...Traders: Rally is intact but needs another green day to confirm. Big mid-cap 4% movers today: AGIO ARNA (up 21.6%) ARRY...
Biotech Bear Market: But It Is Time to Start Trading…11/9 Updates on Rally
Update at Close 11/9/18 Remain Cautious as Rally Fails The NASDAQ down 1.6% and Russell 2000 down 1.8%, sold off killing hopes of a continued Post-Election rally. The biotech sector is for...
Biotech Bull Market Under Pressure: Now Flat to Down in 2018…Rally 10/16!…Updates 10/29 Bear Market
Update 10/29 It's a bear market in biotech so wait for the bottom. Have plenty of cash on hand. IBB at $102.77 down over 5% YTD. Clues: IJR and XBI need to bottom. ======= Update 10/27 Still on...
Biotech Momentum Lost Mired in Macro-Economic News Cycle: China, FED,Trade etc.
Biotech Momentum Lost Technical Breakdown: XBI Near April Bottom but XLV Looks Good Market Looking for Growth from Large Cap Earnings 10 year auction has tepid demand at Yield of 3.225%, NASDAQ at...
Rayno BioBeat #6: Biotech Sell-Off with Broad Market Concerns…Updates
Update 10/5/18 Very Weak Technicals after Biotech Sell-Off NASDAQ market closed off the lows down 1.16% at 7788. Biotech ETF IBB down 1.15% just above 3 month support of 116. Biotech ETF XBI down...
Mid-Cap Biopharma 2018 Stock Performance as of 9/30…Updates
Update-10/1 Rally Fades Early Today...NASDAQ Moves to Red An early rally faded quickly today after an initial spike from new "NAFTA" deal. Biotech ETFs were red IBB down 0.63% and XBI down 1.34%....
Biotech Bounces to Trend Line-Clinical News Lifts Stocks…Update ALXN, TSRO
Update 9/26: FED Rate Hike Curbs Traders but Biotech Rolls On The market dipped slightly then went red about 3:30P EDT resulting in a 0.4% loss for the Dow. Main rates will rise to the 2 to 2.25%...
Biotechs Bounce Back, Dow and S&P Hit New Highs
Biotechs Bounce Back: Up From September Lows-Markets Surge Ahead XBI Up 1.66% to $97.16 up from 3 month tech support of $95;IBB up 1.39%. Broad rally brings Dow up 1%, S&P up 0.81% to fresh...